8-K: WW International Reports Mixed Q4 Results, Oprah Winfrey to Depart Board

WW International announced its Q4 and full year 2023 results, showing subscriber growth but revenue declines, and also revealed that Oprah Winfrey will not seek re-election to the board.

Summary

• WW International reported a 7.1% year-over-year increase in total subscribers to 3.8 million at the end of Q4 2023, driven by digital and clinical subscriptions.
• Q4 2023 revenue was $206 million, a 7.6% decrease compared to the prior year, or 8.7% on a constant currency basis.
• The company's full year 2023 revenue was $889.6 million, a 14.5% decrease year-over-year, or 14.5% on a constant currency basis.
• Adjusted operating income for Q4 2023 was $21.3 million, compared to $23.1 million in the prior year.
• The company reported a net loss of $88.1 million for Q4 2023, compared to a net loss of $35.8 million in the prior year.
• For the full year 2023, the company reported a net loss of $112.3 million, compared to a net loss of $256.9 million in the prior year.
• WW International expects full year 2024 revenue to be between $830 million and $860 million and operating income to be between $100 million and $110 million.
• Oprah Winfrey will not stand for re-election to the board at the 2024 annual meeting, planned for May 9, 2024, and will donate her stock to the National Museum of African American History and Culture.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative. While subscriber growth is positive, the significant revenue decline and net losses are concerning. The departure of Oprah Winfrey from the board adds uncertainty. The company is making strategic shifts, but the financial results are mixed.

Positives

• The company achieved a 7.1% year-over-year increase in total subscribers, marking the first year-end subscriber growth in three years.
• Digital subscriber numbers increased by 8.6% year-over-year in Q4 2023.
• The company's adjusted gross margin improved to 61.4% in Q4 2023, up from 57.9% in the prior year.
• The company is projecting subscriber growth for 2024, expecting to end the year with 3.8 to 4.0 million subscribers.
• The company anticipates a return to year-over-year growth in subscription revenues in the second half of 2024.
• The company's operating loss decreased significantly from $51.8 million to $6.0 million in Q4 2023.

Negatives

• Q4 2023 revenue decreased by 7.6% year-over-year to $206 million.
• Full year 2023 revenue decreased by 14.5% year-over-year to $889.6 million.
• Product sales and other revenue decreased by 55.1% in Q4 2023 and 44.7% for the full year 2023 due to the wind down of the consumer products business.
• The company reported a net loss of $88.1 million for Q4 2023, compared to a net loss of $35.8 million in the prior year.
• The company reported a net loss of $112.3 million for the full year 2023.
• Workshops + Digital subscribers decreased by 8.3% year-over-year in Q4 2023.
• The company recorded $23.1 million in restructuring charges in Q4 2023, higher than the previously estimated $10 million.

Risks

• The company faces competition from other weight management and health and wellness industry participants.
• There is a risk that the company may fail to retain and grow its subscriber base.
• The company's ability to be a leader in the rapidly evolving clinical weight management market is uncertain.
• The company's strategic initiatives may not be successfully implemented.
• The company is exposed to risks related to a downturn in general economic conditions or consumer confidence.
• The company has a substantial amount of debt and debt service obligations.
• The company's technology or systems may not operate satisfactorily.
• The company is exposed to data security breaches and other malicious acts or privacy concerns.
• The company's international operations are subject to regulatory, economic, political, social, intellectual property, and foreign currency risks.
• The company's exposure to extensive and complex healthcare laws and regulations as a result of the acquisition of Sequence is a risk.

Future Outlook

The company expects full year 2024 revenue to be between $830 million and $860 million and operating income to be between $100 million and $110 million. They also anticipate ending 2024 with 3.8 to 4.0 million subscribers, including 140,000 to 160,000 clinical subscribers and a return to year-over-year growth in subscription revenues in the second half of 2024.

Management Comments

• Sima Sistani, the company's CEO, stated that 2023 was a pivotal year as they began transforming the business for the future and that they returned to year-end subscriber growth for the first time in 3 years.
• Heather Stark, the company's CFO, mentioned that they executed against their 2023 objectives with a return to sign up and subscriber growth, record adjusted gross margin, and improved cost structure.
• Oprah Winfrey stated that she looks forward to continuing to advise and collaborate with WeightWatchers and CEO Sima Sistani in elevating the conversation around recognizing obesity as a chronic condition.
• Thilo Semmelbauer, Chairman of the Board, thanked Oprah Winfrey for her energy, dedication, and for continuing to play a role as collaborator and thought partner going forward.

Industry Context

The announcement reflects the ongoing shift in the weight management industry towards digital and clinical offerings, with WW International focusing on expanding its clinical services and digital subscriptions. The departure of Oprah Winfrey from the board may signal a strategic shift or a move to reduce potential conflicts of interest as the company navigates the evolving landscape of weight loss solutions.

Comparison to Industry Standards

• WW International's subscriber growth, particularly in digital and clinical areas, is a positive sign compared to traditional weight loss programs, but the revenue decline indicates challenges in monetizing these subscribers.
• The company's adjusted gross margin of 61.4% in Q4 2023 is competitive with other subscription-based health and wellness companies, but the overall revenue decline is a concern.
• The shift towards clinical offerings is similar to trends seen in other health and wellness companies, such as Teladoc Health and Hims & Hers Health, which are also expanding into telehealth and clinical services.
• The company's net loss of $112.3 million for the full year 2023 is a significant concern compared to some competitors that have achieved profitability or are closer to breaking even.
• The company's restructuring charges and impairment charges are higher than some competitors, indicating potential challenges in managing costs and assets.

Management Changes

Stakeholder Impact

• Shareholders may be concerned about the revenue decline and net losses, but encouraged by the subscriber growth and future outlook.
• Employees may be affected by the ongoing restructuring and changes in the company's strategy.
• Customers may benefit from the expansion of digital and clinical offerings.
• Suppliers may be impacted by the wind down of the consumer products business.
• Creditors may be concerned about the company's debt and financial performance.

Next Steps

• The company will continue to focus on growing its digital and clinical subscriber base.
• The company will work to improve margins and drive operating income growth.
• The company will host an event on Weight Health in May 2024.
• The company will continue to modernize its technology organization.

Key Dates

Keywords

WeightWatchers, WW International, Weight Health, Subscribers, Revenue, Clinical, Digital, Restructuring, Oprah Winfrey, Board of Directors